biontech.de (BNTX): Aggregate Business Value
BioNTech SE (BNTX) is protected by a robust patent portfolio and financial stability, which minimizes pressure from competitors in the immuno-oncology sector. Deep expertise in mRNA methods will provide the company with undeniable pricing power over future anti-cancer drugs. The daily price action reflects that the business value is 5286.43, confirming its status as a recognized global leader in creating revolutionary medical products.
BioNTech SE (BNTX) - metric breakdowns and financial figures
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Comprehensive company analysis:BioNTech Inc. (BNTX)
Enterprise value combines market capitalization and net debt, determining the actual cost of a full buyout of BioNTech SE (BNTX) while accounting for its liquidity. The enterprise value trend reflects how large-scale investments in the oncology platform for business diversification impact the company's overall valuation, allowing investors to distinguish the real value of assets from fluctuations in share prices.
Competitor analysis for BioNTech SE
ARGX - Business Value|Real Price to Acquire Entire Company Abivax S.A. ABVX|ADMA Corp (ADMA) - Aggregate Business Value|Real Price to Acquire Entire Company Protagonist Therapeutics|IMVT (immunovant.com) - Business Value|Total Company Value Kiniksa KNSA|Full Business Value Grifols SA|Adaptive Biotechnologies Corp (ADPT) - Enterprise Value|Value Adjusted for Debt and Cash Celldex Corp (CLDX)|Enterprise Value AUPH (Aurinia Pharmaceuticals)|biocryst.com - Enterprise Value|Total Company Value Vera Therapeutics (VERA)|DNTH: Value Adjusted for Debt and Cash|PHVS (Pharvaris Corp) - Total Company Value|AbCellera Biologics Inc. (ABCL) - Real Price to Acquire Entire Company|TRML (Tourmaline Bio, Inc.) - Enterprise Value|Enterprise Value precigen.com (PGEN)|Pharming Group (PHAR) - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash Nektar Therapeutics Inc (NKTR)|Enterprise Value UPB|Zenas Corp - Company Buyout Price|IMNM: Total Company Value|GOSS: Real Price to Acquire Entire Company|KALV (KalVista Pharmaceuticals, Inc.) - Total Company Value|Real Price to Acquire Entire Company Septerna, Inc.|PVLA (Pieris Pharmaceuticals Inc) - Real Price to Acquire Entire Company|Enterprise Value SVRA|Total Company Value Rigel Pharmaceuticals RIGL|Business Value anaptysbio.com (ANAB)|ATXS: Enterprise Value|Total Enterprise Value enGene Holdings Inc ENGN|RAPT - Enterprise Value|JBIO - Total Company Value|Aclaris Therapeutics - Enterprise Value|KYTX (kyvernatx.com) - Company Buyout Price|Total Company Value TLSA (Tiziana Life Sciences Ltd)|Total Enterprise Value CABA|Total Company Value Ventyx Bio VTYX|Business Value Theratechnologies, Inc THTX|Real Price to Acquire Entire Company Avalo Therapeutics, Inc (AVTX)|Aggregate Business Value eledon.com ELDN|AGEN (Agenus Inc.) - Enterprise Value|CLYM - Total Enterprise Value|ZURA (Zura Bio) - Enterprise Value|aTyr Pharmaceuticals (ATYR) - Real Price to Acquire Entire Company|ADAG - Enterprise Value|Value Adjusted for Debt and Cash Ikena Oncology, Inc. (IMA)|Shattuck Labs, Inc. (STTK) - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash EQ (equilliumbio.com)|Total Company Value CNTB|Company Buyout Price Immunic Therapeutics IMUX|ATRA (Atara Biotherapeutics Inc) - Enterprise Value|IFRX - Total Enterprise Value|X4 Pharmaceuticals, Inc. (XFOR) - Enterprise Value|ACET (Adicet Bio, Inc.) - Total Company Value|Total Company Value Celularity Inc (CELU)|Business Value INmune Bio Corporation (INMB)|Real Price to Acquire Entire Company Barinthus Biotherapeutics|Aggregate Business Value kezarlifesciences.com KZR|SABS - Real Price to Acquire Entire Company|Akari Therapeutics PLC - Business Value|Total Company Value Enlivex Therapeutics, Ltd.|QTTB - Full Business Value|Enterprise Value GeoVax Labs, Inc. GOVX|edesabiotech.com (EDSA) - Value Adjusted for Debt and Cash|IBIO (iBio) - Enterprise Value|Enterprise Value CARM|XTL Biopharmaceuticals, Ltd. (XTLB) - Total Company Value|Value Adjusted for Debt and Cash BOLT (boltbio.com)|HCW Biologics - Total Company Value|Real Price to Acquire Entire Company Aptevo Therapeutics, Inc. APVO|AIM ImmunoTech Inc. - Enterprise Value|Aditxt (ADTX) - Enterprise Value|Real Price to Acquire Entire Company GRI Bio Corp GRI|XORTX Corp (XRTX) - Value Adjusted for Debt and Cash|HIND: Enterprise Value|Company Buyout Price REVB|Total Company Value INDP (Indaptus Therapeutics, Inc.)|Real Price to Acquire Entire Company SCNI (Scinai Immunotherapeutics Ltd)|CalciMedica - Total Company Value|AFMD - Real Price to Acquire Entire Company|Allakos Therapeutics - Real Price to Acquire Entire Company|HOOK: Enterprise Value|Total Company Value igmbio.com|iTeos Therapeutics Inc (ITOS) - Business Value|Enterprise Value OCEA (Ocean Bio)|Total Enterprise Value TC BioPharm Ltd|Enterprise Value Third Harmonic Bio (THRD)